Related people
Johannes Schaadt-Wambach, LL.M. (Prag)
Johannes Schaadt-Wambach is a member of the Practice Area Competition, EU & Trade. His practice focuses on EU state aid law, general EU law, public procurement law and foreign trade law.
Johannes Schaadt-Wambach advises private companies as well as the public sector in the preparation and implementation of public procurement procedures. In addition, he advises on all questions of EU state aid law, general EU law and foreign trade law. Mr. Schaadt-Wambach studied law at University of Saarland and Charles University in Prague.
Show full CV
Hide full CV
More
Show less
More
Show less
Career
| Since 2023 | Senior Associate, Taylor Wessing |
| 2020 - 2023 | Associate, Taylor Wessing |
| 2018 – 2019 | Associate, international law firm |
| 2017 | Legal Trainee, Permanent Mission of the Federal Republic of Germany to the United Nations in Geneva |
Education
| 2019 – 2021 | LL.M. at Charles University in Prague (European and International Business Law) |
| 2018 | Admission to the bar in Cologne |
| 2016 – 2018 | Legal clerkship at Higher Regional Court of Cologne |
| 2009 – 2015 | Legal studies at Saarland University and Charles University in Prague |
Publications
| Krankenhauszukunftsgesetz (KHZG) Erfahrungen aus dem Beratungsalltag, in: Health&Care Management, 07/2021, gemeinsam mit Michael Brüggemann und Vanessa Christin Vollmar |
Additional languages
| English, French |
Latest news & insights
Competition, EU & trade
Click here to find out more
Conversion to eForms – what public contracting authorities need to know
30 March 2023
Briefing
by multiple authors
Corporate/M&A & capital markets
Click here to find out more
Taylor Wessing advises NORD Holding and Zentrum Gesundheit on the acquisition of REALEYES Group
1 February 2022
by multiple authors
Corporate/M&A & capital markets
Click here to find out more
Taylor Wessing advises Hillenbrand, Inc. on the sale of ABEL Pumps to IDEX Corporation
13 January 2021
by multiple authors
Life sciences & healthcare
Click here to find out more
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18 April 2024
In-depth analysis